Skip to search formSkip to main contentSkip to account menu

Moclobemide

Known as: Moclobamide, 4-Chlor-N-(2-morpholinoethyl)benzamid, Moclobemida 
A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
National Institutes of Health

Related topics

Related topics

21 relations

Broader (2)

Antidepressive AgentsMonoamine Oxidase Inhibitors

Narrower (11)

ArimaAurorixChem mart MoclobemideDBL Moclobemide
In BloodMoclobemide:MCnc:Pt:Ser/Plas:QnMoclobemide:SCnc:Pt:Ser/Plas:Qnagonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Moclobemide‐Induced Hypersexuality in Patients With Stroke and Parkinson's Disease
Decline in sexual activities caused by diseases or by medication affecting the functions of the central nervous system has often… 
1997
1997
A fatality involving moclobemide, sertraline, and pimozide.
A case is described involving a suspected fatal interaction between moclobemide and sertraline, in combination with the use of… 
1995
1995
The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's disease.
Dopamine is equally well deaminated oxidatively by monoamine oxidase (MAO) A and B types. Selegiline (L-deprenyl), a selective… 
Review
1995
Review
1995
Moclobemide safety: monitoring a newly developed product in the 1990s.
Moclobemide is a reversible and selective inhibitor of monoamine oxidase subtype A with a wide spectrum of antidepressant… 
Highly Cited
1993
Highly Cited
1993
A double‐blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders
Moclobemide and fluoxetine were tested in a six-week trial involving 122 patients with major depressive illness. Patients… 
Highly Cited
1993
Highly Cited
1993
The sleep eeg and nocturnal hormonal secretion studies on changes during the course of depression and on effects of cns-active drugs
1993
1993
Efficacy of moclobemide in different patient groups. Results of new subscales of the Hamilton Depression Rating Scale.
Data from 38 double-blind and two single-blind studies with moclobemide vs. placebo and/or standard antidepressants (10 drugs… 
Highly Cited
1993
Highly Cited
1993
Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: A study in healthy volunteers
The antinociceptive effect of three antidepressants with different postulated modes of action, 75 mg desipramine, 225 mg… 
Review
1993
Review
1993
Moclobemide — Placebo‐controlled trials
In this paper, three placebo-controlled trials of moclobemide, and four three-way comparison trials of moclobemide, placebo and… 
1990
1990
Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors
The pharmacodynamic properties of moclobemide, a reversible inhibitor of MAO‐A (RIMA), were compared with the properties of other… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)